Avonex 30 MCG/0.5 ML SYR (4PK)s
Ended Awarded
- Contract number
- SPE2DB26FDS27
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,641
Award facts
- Contract value 100% obligated
- $27,640.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,640.82 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Avonex 30 MCG/0.5 ML syringes in four-packs. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 21, 2025. Avonex is a disease-modifying therapy commonly used to treat multiple sclerosis, supporting the broader federal medical supply mission for military and veteran healthcare systems.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement and supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This delivery order exemplifies the company's role as a prime vendor within DLA's pharmaceutical supply chain, providing essential medications and medical supplies to support Department of Defense healthcare programs. The non-set-aside designation and firm fixed-price structure are consistent with AmerisourceBergen's standard federal contracting approach, demonstrating its capability to fulfill government medical needs through competitive federal procurement mechanisms.
Quick answers
Who was awarded contract SPE2DB26FDS27?
SPE2DB26FDS27 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FDS27 worth?
The government has obligated $27,641 on SPE2DB26FDS27.
Is contract SPE2DB26FDS27 an order under another contract?
Yes. SPE2DB26FDS27 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDS27 competed?
The extent of competition for SPE2DB26FDS27 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award